Discover the Science of Health
Researchers from Saarland University and Siemens Healthcare report that a new blood test can accurately discriminate between healthy people and patients with Alzheimer’s disease. It’s hoped the non-invasive and relatively cheap test could one day help with diagnosis. The research is published in the open access journal Genome Biology [2].
Watermelon juice is a popular drink among athletes, who have long praised it for replenishing fluids, electrolytes and glucose that get depleted during a workout. A new study identifies an additional benefit: juice from the summer fruit can relieve post-exercise muscle pain [1]. The study is published in the American Chemical Society’s Journal of Agricultural and Food Chemistry.
The Atlantic recently published an excerpt from Dr. Paul Offit’s book Do You Believe in Magic?: The Sense and Nonsense of Alternative Medicine, which takes a closer look at the vitamin supplement industry and the harm it is inflicting [1].
Biomarker Bulletin is an occasionally recurring update of news focused on biomarkers aggregated at BiomarkerCommons.org. Biomarkers are physical, functional or biochemical indicators of normal physiological or disease processes. The individualization of disease management — personalized medicine — is dependent on developing biomarkers that promote specific clinical domains, including early detection, risk, diagnosis, prognosis and predicted response to therapy.
The non-profit One Mind recently announced a partnership with the Intellectual Property & Science business of Thomson Reuters to further the understanding of traumatic brain injuries (TBI) and the central nervous system (CNS) [1]. The relationship will enable researchers to collaborate and share research results on a single web platform.
